Your email has been successfully added to our mailing list.

×
-0.00130855796911796 -0.00255168803978007 -0.00130855796911796 -0.00811305940853186 -0.00314053912588321 -0.00300968332897153 0.000654278984558979 -0.00915990578382626
Stock impact report

ViaCyte's Stem Cell-Derived Treatment For Type 1 Diabetes Shows Promising Results In Two Published Studies [TheStreet.com]

CRISPR Therapeutics AG - Common Shares (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
Company Research Source: TheStreet.com
SAN DIEGO, Dec. 2, 2021 /PRNewswire/ --, a clinical-stage regenerative medicine company focused on developing novel cell replacement therapies to address diseases with significant unmet needs, announced publication of promising preliminary results of an ongoing, first-in-human Phase 1/2 study demonstrating that its stem cell-derived therapy can produce insulin in people with severe type 1 diabetes (T1D). The findings were published today in and. "The data from these papers represent a significant scientific advance," said Cell Reports Medicine study lead author James Shapiro, MD PhD, Canada Research Chair and Director of the Islet Transplant Program at the University of Alberta, Canada. "It is the first reported evidence that differentiated stem cells implanted in patients can generate meal-regulated insulin secretion, offering real hope for the incredible potential of this treatment." The Cell Reports Medicine paper reports on 17 patients who were implanted with ViaCyte's PEC-Direc Show less Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CRSP alerts
Opt-in for
CRSP alerts

from News Quantified
Opt-in for
CRSP alerts

from News Quantified